ITCI logo

Intra-Cellular Therapies (ITCI) Shareholders Equity

Annual Shareholders Equity

$1.15 B
+$557.04 M+94.19%

December 31, 2024


Summary


Performance

ITCI Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherITCIbalance sheetmetrics:

Quarterly Shareholders Equity

$1.15 B
+$3.63 M+0.32%

December 31, 2024


Summary


Performance

ITCI Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherITCIbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

ITCI Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+94.2%+0.3%
3 y3 years+174.8%+91.2%
5 y5 years+488.9%+91.2%

ITCI Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+174.8%at high+174.8%
5 y5-yearat high+488.9%at high+488.9%
alltimeall timeat high>+9999.0%at high>+9999.0%

Intra-Cellular Therapies Shareholders Equity History

DateAnnualQuarterly
Dec 2024
$1.15 B(+94.2%)
$1.15 B(+0.3%)
Sep 2024
-
$1.14 B(+0.0%)
Jun 2024
-
$1.14 B(+90.9%)
Mar 2024
-
$599.50 M(+1.4%)
Dec 2023
$591.42 M(-9.9%)
$591.42 M(-1.5%)
Sep 2023
-
$600.68 M(-1.1%)
Jun 2023
-
$607.09 M(-3.3%)
Mar 2023
-
$627.61 M(-4.3%)
Dec 2022
$656.07 M(+57.0%)
$656.07 M(-4.3%)
Sep 2022
-
$685.42 M(-5.1%)
Jun 2022
-
$722.20 M(-8.9%)
Mar 2022
-
$792.75 M(+89.7%)
Dec 2021
$417.89 M(-36.4%)
$417.89 M(-14.1%)
Sep 2021
-
$486.76 M(-12.1%)
Jun 2021
-
$553.59 M(-9.6%)
Mar 2021
-
$612.15 M(-6.8%)
Dec 2020
$656.86 M(+236.8%)
$656.86 M(-7.4%)
Sep 2020
-
$709.40 M(+86.9%)
Jun 2020
-
$379.53 M(-11.8%)
Mar 2020
-
$430.45 M(+120.7%)
Dec 2019
$195.01 M(-38.6%)
$195.01 M(-14.0%)
Sep 2019
-
$226.88 M(-11.6%)
Jun 2019
-
$256.77 M(-11.0%)
Mar 2019
-
$288.61 M(-9.2%)
DateAnnualQuarterly
Dec 2018
$317.71 M(-30.1%)
$317.71 M(-10.2%)
Sep 2018
-
$353.63 M(-9.4%)
Jun 2018
-
$390.39 M(-7.8%)
Mar 2018
-
$423.19 M(-6.9%)
Dec 2017
$454.44 M(+21.0%)
$454.44 M(+42.3%)
Sep 2017
-
$319.44 M(-6.0%)
Jun 2017
-
$339.67 M(-3.8%)
Mar 2017
-
$353.03 M(-6.0%)
Dec 2016
$375.50 M(-21.2%)
$375.50 M(-6.0%)
Sep 2016
-
$399.32 M(-6.3%)
Jun 2016
-
$425.96 M(-5.9%)
Mar 2016
-
$452.74 M(-4.9%)
Dec 2015
$476.24 M(+295.0%)
$476.24 M(-5.1%)
Sep 2015
-
$501.85 M(+146.5%)
Jun 2015
-
$203.57 M(-8.5%)
Mar 2015
-
$222.38 M(+84.5%)
Dec 2014
$120.55 M(+281.3%)
$120.55 M(-10.1%)
Sep 2014
-
$134.03 M(-3.3%)
Jun 2014
-
$138.60 M(-2.9%)
Mar 2014
-
$142.72 M(+351.4%)
Dec 2013
$31.62 M(<-9900.0%)
$31.62 M(-20.1%)
Sep 2013
-
$39.56 M(<-9900.0%)
Jun 2013
-
-$33.00 K
Mar 2013
-$22.10 K
-

FAQ

  • What is Intra-Cellular Therapies annual stockholders equity?
  • What is the all time high annual shareholders equity for Intra-Cellular Therapies?
  • What is Intra-Cellular Therapies annual shareholders equity year-on-year change?
  • What is Intra-Cellular Therapies quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Intra-Cellular Therapies?
  • What is Intra-Cellular Therapies quarterly shareholders equity year-on-year change?

What is Intra-Cellular Therapies annual stockholders equity?

The current annual shareholders equity of ITCI is $1.15 B

What is the all time high annual shareholders equity for Intra-Cellular Therapies?

Intra-Cellular Therapies all-time high annual stockholders equity is $1.15 B

What is Intra-Cellular Therapies annual shareholders equity year-on-year change?

Over the past year, ITCI annual stockholders equity has changed by +$557.04 M (+94.19%)

What is Intra-Cellular Therapies quarterly stockholders equity?

The current quarterly shareholders equity of ITCI is $1.15 B

What is the all time high quarterly shareholders equity for Intra-Cellular Therapies?

Intra-Cellular Therapies all-time high quarterly stockholders equity is $1.15 B

What is Intra-Cellular Therapies quarterly shareholders equity year-on-year change?

Over the past year, ITCI quarterly stockholders equity has changed by +$3.63 M (+0.32%)